Basal Cell Carcinoma Chemoprevention Trial

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,630

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

January 1, 2032

Study Completion Date

January 1, 2032

Conditions
Basal Cell Carcinoma
Interventions
DRUG

5% Imiquimod cream

Topical 5% Imiquimod cream will be applied once daily to the face in a thin layer for 12 weeks. Three packets of cream will be defined as one dose or application. The cream should be applied to the face prior to normal sleeping hours (it is readily absorbed) and left on the skin for 6-10 hours (i.e. overnight). Rest periods will be allowed if bothersome side effects occur.

DRUG

Placebo Vehicle Control Cream

The placebo vehicle control cream will be a virtually identical cream (to the Imiquimod cream) that contains no Imiquimod. This cream will be applied once daily to the face in a thin layer for 12 weeks. Three packets of cream will be defined as one dose or application. The cream should be applied to the face prior to normal sleeping hours (it is readily absorbed) and left on the skin for 6-10 hours (i.e. overnight). Rest periods will be allowed if bothersome side effects occur.

Trial Locations (1)

02908-4734

Providence VA Medical Center, Providence, RI, Providence

All Listed Sponsors
lead

VA Office of Research and Development

FED